RS50500B - The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining - Google Patents

The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining

Info

Publication number
RS50500B
RS50500B YUP-235/02A YUP23502A RS50500B RS 50500 B RS50500 B RS 50500B YU P23502 A YUP23502 A YU P23502A RS 50500 B RS50500 B RS 50500B
Authority
RS
Serbia
Prior art keywords
procedure
obtaining
pharmaceutical preparation
methylprednisolone
effervescent pharmaceutical
Prior art date
Application number
YUP-235/02A
Other languages
Serbian (sr)
Inventor
Branka Palurović
Biljana Stupar
Ljiljana Solomun
Slobodan PETROVIĆ
Original Assignee
Hemofarm A.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemofarm A.D. filed Critical Hemofarm A.D.
Priority to YUP-235/02A priority Critical patent/RS50500B/en
Publication of YU23502A publication Critical patent/YU23502A/en
Publication of RS50500B publication Critical patent/RS50500B/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Farmaceutski proizvod u obliku efervescentne tablete, naznačen time, što se sastoji od efervescentnog granulata koga čine stabilizovana jezgra sa metilprednizolon hidrogensukcinatom ili natrijumovom soli metilprednizolon sukcinata, natrijum i/ili kalijum karbonat i dokusat natrijum, obložena slojem ) citratno-puferne supstance i ostale farmaceutski prihvatljive komponente.Prijava sadrži još 5 patentnih zahteva.Pharmaceutical product in the form of an effervescent tablet, consisting of an effervescent granulate consisting of a stabilized nucleus with methylprednisolone hydrogensuccinate or the sodium salt of methylprednisolone succinate, sodium and / or potassium carbonate and docusate sodium, citrate acceptable components.The application contains 5 more patent claims.

YUP-235/02A 2002-03-29 2002-03-29 The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining RS50500B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YUP-235/02A RS50500B (en) 2002-03-29 2002-03-29 The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YUP-235/02A RS50500B (en) 2002-03-29 2002-03-29 The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining

Publications (2)

Publication Number Publication Date
YU23502A YU23502A (en) 2006-01-16
RS50500B true RS50500B (en) 2010-03-02

Family

ID=47747123

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-235/02A RS50500B (en) 2002-03-29 2002-03-29 The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining

Country Status (1)

Country Link
RS (1) RS50500B (en)

Also Published As

Publication number Publication date
YU23502A (en) 2006-01-16

Similar Documents

Publication Publication Date Title
HK1067544A1 (en) Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE69620606D1 (en) FIXED ORAL APPLICATION FORM
EA200000245A1 (en) QUICKLY DISINTEGRATING METAL CELLULOSE TABLETS
ME00008B (en) Composition comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent
PT1727551E (en) Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein
YU53101A (en) Core tablet for controlled release of gliclazide after oral administration
ES2192227T3 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE OF REVERSIBLE INHIBITORS OF PUMPS OF PROTONS.
PT1727550E (en) Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
ATE329579T1 (en) SOLID DISPERSION WITH RITONAVIR, FENOFIBRATE OR GRISEOFULVIN
NO20042161L (en) Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
TW200510375A (en) New compounds
HRP20041152B1 (en) Pharmaceutical formulations
IS7413A (en) New 1,2,3-substituted indolysin derivatives, inhibitors of the FGFS, their method of manufacture and pharmaceutical compositions containing them
WO2005007137A3 (en) Tablets containing ambroxol
SG116507A1 (en) Pharmaceutical dosage form and method of making.
AU2003285143A1 (en) Analysis of pharmaceutical solubility and stability
ZA200506992B (en) Fibrate tablet and method for the production thereof
PT1213974E (en) DIRECTLY COMPRESSIVE BRIGHT SUBSTANCE FOR TABLETS
HRP20050055B1 (en) Microcapsules for the delayed, controlled release of perindopril
IL137489A0 (en) Pharmaceutical compositions containing inhibitors of the lymphotoxin pathway
RS50500B (en) The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining
HRP20000781B1 (en) Effervescent preparations
AR034435A1 (en) THERAPEUTIC AGENTS.
DE60004204D1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THE PRODUCTION THEREOF
ATE266404T1 (en) A STABLE PHARMACEUTICAL FORMULATION CONTAINING TORSEMIDE MODIFICATION II